It’s a certain drive to question the answers and go beyond convention that makes research at Monash different. We believe that great research, when properly applied, can lead to lasting and positive change in the world.
The management of Australia’s looming energy crisis has so far focused almost exclusively on the supply side of the equation: exploiting new gas reserves, expanding the Snowy Mountains hydro scheme, and building new infrastructure.
Melbourne-based drug developer Cancer Therapeutics CRC (CTx) has received a sought-after award in recognition of its work on novel oncology drug candidates, based on early research conducted at Monash University.
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI)researchers, in collaboration with the Monash Institute of Pharmaceutical Sciences (MIPS), have shed light on a key aspect of the process. Their findings may help guide the development of new treatments of inflammatory diseases such as atherosclerosis, which can lead to heart attack or stroke, and type 2 diabetes.